BIMI - NF Energy Saving Corp Stock Price, Fair Value and News

1.17USD+0.02 (+1.74%)Delayed as of 17 May 2024, 11:07 am ET

Market Summary

USD1.17+0.02

Delayedas of 17 May 2024, 11:07 am

1.74%

BIMI Stock Price

View Fullscreen

BIMI RSI Chart

BIMI Valuation

Market Cap

13.3M

Price/Earnings (Trailing)

-1.53

Price/Sales (Trailing)

1.24

EV/EBITDA

-1.47

Price/Free Cashflow

-6.35

BIMI Price/Sales (Trailing)

BIMI Profitability

Operating Margin

36.25%

EBT Margin

-103.41%

Return on Equity

-138.6%

Return on Assets

-34.44%

Free Cashflow Yield

-15.74%

BIMI Fundamentals

BIMI Revenue

Revenue (TTM)

11.8M

BIMI Earnings

Earnings (TTM)

-12.1M

Earnings Growth (Yr)

19.42%

Earnings Growth (Qtr)

-396.86%

Breaking Down BIMI Revenue

52 Week Range

1.19

(Low)(High)

Last 7 days

2.7%

Last 30 days

-27.7%

Last 90 days

-62.3%

Trailing 12 Months

40.2%

How does BIMI drawdown profile look like?

BIMI Financial Health

Current Ratio

1.21

Debt/Equity

Debt/Cashflow

-118.99

BIMI Investor Care

Shares Dilution (1Y)

201.54%

Diluted EPS (TTM)

-8.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2022	18.9M	16.6M	14.2M	11.8M
2021	14.6M	20.0M	30.7M	21.3M
2020	3.3M	6.5M	9.7M	12.8M
2019	7.0M	6.7M	5.8M	158.0K
2018	8.0M	7.5M	7.0M	6.5M
2017	5.5M	6.5M	6.3M	8.5M
2016	7.1M	6.5M	5.2M	6.0M
2015	9.4M	9.1M	8.8M	6.7M
2014	6.1M	6.2M	7.9M	10.0M
2013	9.4M	7.5M	7.1M	5.7M
2012	13.5M	11.9M	11.1M	9.3M
2011	22.8M	20.2M	17.5M	14.9M
2010	0	0	0	25.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of NF Energy Saving Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 28, 2024	tiewei song	sold	-16,300	4.075	-4,000	ceo
Feb 26, 2024	tiewei song	sold	-2,903	4.01	-724	ceo
Jan 02, 2024	bimi holdings inc.	acquired	3,000,000	1.5	2,000,000	-
Jan 02, 2024	oudom fnu	acquired	3,000,000	1.5	2,000,000	-
Dec 28, 2023	bimi holdings inc.	acquired	496,853	1.2	414,044	-
Dec 28, 2023	oudom fnu	acquired	496,853	1.2	414,044	-
Dec 06, 2023	oudom fnu	acquired	-	-	5,000,000	-
Jun 19, 2023	oudom fnu	acquired	3,615,000	2.25938	1,600,000	-
Jul 19, 2022	tiewei song	acquired	4,984,000,000	49,840	100,000	ceo
Jul 19, 2022	oudom fnu	acquired	5,000,000	0.4	12,500,000	chaiman

Which funds bought or sold BIMI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 13, 2024	NATIXIS	unchanged	-	-4,420	11,222	-%
May 13, 2024	UBS Group AG	sold off	-100	-1,995	-	-%
May 10, 2024	JPMORGAN CHASE & CO	reduced	-99.98	-11,101	2.00	-%
May 10, 2024	OSAIC HOLDINGS, INC.	added	1.72	-169	595	-%
May 10, 2024	WELLS FARGO & COMPANY/MN	new	-	5.00	5.00	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Apr 29, 2024	COMMONWEALTH EQUITY SERVICES, LLC	new	-	18,000	18,000	-%
Apr 19, 2024	Financial Perspectives, Inc	unchanged	-	-5.00	13.00	-%

Are Funds Buying or Selling BIMI?

Are funds buying BIMI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BIMI

No. of Funds

Unveiling NF Energy Saving Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jan 11, 2024	oudom fnu	73.30%	10,264,044	SC 13D/A
Dec 19, 2023	oudom fnu	67.73%	7,850,000	SC 13D/A
Aug 02, 2022	tiewei song	4.72%	1,339,027	SC 13D/A
Jun 21, 2022	tiewei song	6.63%	1e+06	SC 13D
Mar 03, 2022	hudson bay capital management lp	4.99%	1,920,509	SC 13G/A
Feb 02, 2022	hudson bay capital management lp	5.33%	1,950,000	SC 13G/A
Feb 08, 2021	hudson bay capital management lp	8.99%	1,050,000	SC 13G

Recent SEC filings of NF Energy Saving Corp

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	8-K	Current Report
Apr 02, 2024	NT 10-K	NT 10-K
Mar 28, 2024	8-K	Current Report
Mar 20, 2024	3	Insider Trading
Mar 04, 2024	4	Insider Trading
Mar 04, 2024	4	Insider Trading

Peers (Alternatives to NF Energy Saving Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	371.3B	85.6B	6.80%	-2.97%	9.65	4.33	5.68%	202.39%
MRK	331.6B	61.4B	4.69%	14.08%	143.8	5.4	6.11%	-82.30%
AMGN	168.9B	29.5B	18.50%	39.89%	44.87	5.72	12.76%	-52.47%
PFE	163.9B	57.8B	12.61%	-21.28%	130.78	2.84	76.51%	-86.81%
GILD	84.6B	27.4B	0.85%	-13.87%	174.55	3.08	1.51%	-91.32%
TEVA	18.5B	16.0B	24.52%	100.49%	-37.33	1.15	7.23%	71.10%
MID-CAP
ALKS	4.1B	1.7B	2.99%	-21.03%	9.53	2.4	54.01%	364.56%
PRGO	4.1B	4.6B	0.47%	-8.40%	-532.89	0.9	-0.06%	94.55%
BHC	2.6B	9.0B	-19.11%	-5.35%	-5.7	0.29	10.01%	-27.45%
AMPH	2.1B	676.2M	4.47%	-0.56%	13.51	3.09	30.38%	66.04%
SMALL-CAP
TLRY	1.6B	743.2M	16.39%	-11.62%	-4.68	2.22	24.65%	80.36%
TXMD	24.2M	1.3M	10.53%	-49.88%	-3.27	18.6	-98.14%	-104.71%
ACRX	19.7M	89.6M	13.73%	58.80%	-1.39	0.19	287.27%	-129.41%
AGRX	2.6M	21.5M	2.56%	-90.89%	-0.34	0.12	66.16%	61.83%
ACOR	633.5K	115.7M	-50.00%	-97.38%	0	0.01	-2.22%	-352.48%

NF Energy Saving Corp News

Latest updates

NF Energy Saving Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2	2018Q1	2017Q4
Revenue	-100.0%	-	7,314,842	4,927,361	5,019,748	9,398,621	13,777,494	9,256,987	2,168,004	5,531,722	3,091,071	3,803,257	414,584	311,493	208,402	333,690	578,712	4,728,121	1,102,693	564,339	2,608,574	4,652,808
Cost Of Revenue	-77.5%	952,291	4,229,316	2,356,455	2,342,367	-1,722,612	11,748,385	7,292,152	1,575,743	4,162,820	2,833,793	3,071,476	332,299	-726,742	281,014	319,172	430,676	4,737,994	956,694	272,548	115,642	4,197,855
Gross Profit	-42.8%	401,864	703,163	472,579	372,344	-2,160,262	2,029,109	1,964,835	592,261	1,368,902	257,278	731,781	82,285	-236,084	-72,612	14,518	148,036	-9,873	145,999	291,791	31,437	454,953
Operating Expenses	170.0%	8,411,307	3,115,686	3,239,365	2,522,046	24,815,588	3,574,443	2,115,279	3,832,650	-79,481	1,689,962	2,989,489	1,406,022	-422,338	359,307	726,940	122,614	-2,441,691	370,703	1,835,440	448,130	804,691
S&GA Expenses	12.9%	350,673	310,475	296,063	345,564	-276,196	1,202,387	774,378	452,636	-245,562	377,977	609,600	41,070	96,971	33,096	48,851	37,873	111,246	6,153	7,449	8,940	-18,806
EBITDA Margin	38.4%	-1.79	-2.91	-2.40	-1.79	-1.61	-0.34	-0.49	-0.33	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	10.5%	38,725	35,038	48,581	48,136	-31,718	84,310	93,882	44,355	-478,550	339,780	48,236	21,684	-401,026	174,488	173,526	151	-245,475	92,769	108,708	330	-125
Income Taxes	88.4%	-110	-949	4,222	2,929	-8,259	5,930	13,255	18,748	296,411	93,356	43,271	1,268	-	-	-	-	3.00	16.00	98.00	-	21.00
Earnings Before Taxes	-203.6%	-9,413,868	-3,100,611	-6,135,122	-2,972,713	-29,425,636	-1,703,946	-262,484	-3,271,879	-4,501,016	-1,767,217	4,662,773	-1,345,966	227,434	-547,689	-883,245	-122,614	2,258,858	-314,875	-1,651,526	-505,039	-465,907
EBT Margin	37.7%	-1.83	-2.93	-2.43	-1.81	-1.63	-0.32	-0.49	-0.33	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-134.5%	-9,107,775	-3,883,605	-6,544,900	-2,974,560	-29,673,297	-1,703,432	-275,985	-3,333,242	-2,532,525	-1,909,947	4,640,264	-2,194,875	-2,464,406	-544,469	-862,096	-567,594	-14,327,188	-310,115	-1,649,507	-499,699	-465,286
Net Income Margin	37.3%	-1.90	-3.03	-2.47	-1.83	-1.64	-0.26	-0.40	-0.21	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cashflow	-56.9%	-2,102,078	-1,339,871	3,297,728	-3,863,745	-327,038	1,005,424	-1,895,839	-1,765,811	-	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-4.4%	35,041	36,658	36,274	34,094	33,003	40,217	38,712	38,128	63,079	62,612	49,747	33,202	33,572	37,308	42,852	30,062	24,364	25,036	24,252	23,051	36,391
Current Assets	-6.3%	24,367	25,995	24,978	23,416	17,384	24,177	22,054	21,160	26,303	25,626	21,697	25,184	25,465	22,405	27,705	30,062	5,213	5,103	3,652	23,051	15,593
Cash Equivalents	-48.5%	994	1,932	1,730	2,337	1,047	5,034	1,606	4,609	210	627	2,835	135	11,587	109	176	2.00	246	276	302	197	202
Inventory	-1.3%	7,087	7,183	8,465	7,654	1,230	3,028	2,170	2,239	2,117	5,117	3,569	950	4,195	2,523	3,196	708	1,532	1,155	1,168	938	4,440
Net PPE	-1.1%	1,672	1,690	1,792	1,703	2,884	3,112	3,344	1,946	-	-	-	707	-	-	-	-	16,803	17,502	18,102	17,958	18,294
Goodwill	0%	2,066	2,066	2,066	2,066	8,376	8,376	8,376	8,376	30,443	30,443	24,512	6,686	6,443	6,443	6,686	-	-	-	-	-	-
Liabilities	3.1%	24,900	24,146	27,654	28,877	22,793	25,821	25,318	26,792	28,291	31,974	25,275	16,309	20,164	23,161	33,899	21,549	14,557	14,419	14,588	13,065	12,512
Current Liabilities	4.0%	20,158	19,391	22,609	23,742	18,899	21,509	20,694	22,092	24,187	27,657	23,453	15,565	20,025	22,997	33,713	21,549	14,557	14,419	14,588	13,065	12,512
Short Term Borrowings	0.1%	1,137	1,135	829	818	1,383	1,657	1,792	769	1,143	916	1,055	839	866	834	833	-	5,653	5,817	5,940	5,817	5,825
Long Term Debt	-80.7%	24.00	126	160	315	475	472	529	538	795	924	-	721	3,616	3,853	402	107	4.00	-	-	-	-
LT Debt, Current	-	-	-	774	1,109	6,320	6,320	5,766	5,211	4,832	5,133	5,133	3,328	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-80.7%	24.00	126	160	315	475	472	529	538	795	924	-	721	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-30.4%	8,707	12,512	6,499	4,048	9,798	14,157	13,252	11,193	34,530	30,387	24,252	16,893	13,284	14,072	9,082	15,651	9,961	10,772	9,800	9,985	23,837
Retained Earnings	-4.6%	-71,429	-68,298	-71,027	-70,143	-	-	-	-47,900	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional Paid-In Capital	2.0%	78,998	77,417	77,424	71,899	65,760	65,834	60,566	55,228	49,580	43,618	37,363	26,356	24,082	22,626	18,360	15,644	14,595	14,595	12,555	12,555	12,555
Shares Outstanding	6.6%	6,673	6,259	4,035	3,765	24,038	15,430	10,088	850	2,708	474	403	265	200	-	-	-	-	-	-	-	-
Minority Interest	-11.7%	1,435	1,626	1,014	1,170	412	238	142	143	259	251	219	183	124	75.00	-128	-170	-153	-154	-136	-150	43.00
Float	-	-	-	-	-	-	-	-	-	-	31,214	24,914	-	-	-	-	-	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-160.1%	-1,483	-570	2,818	-3,663	-2,901	1,736	-5,425	-1,888	1,042	-1,859	-1,729	-702	614	-2,630	-798	-1,128	-909	-394	368	-1,082	638
Share Based Compensation	-	-	-	-	-	830	-	-	-	-	-	585	-	-	-	-	-	-	-	-	-	-
Cashflow From Investing	-	-	-	-	-356	-	-	1,678	3,115	-1,516	-326	39.00	-11,073	10,254	-	95.00	738	-	-	-	-	-99*
Cashflow From Financing	212.7%	1,033	330	-2,167	4,276	-296	5,249	-794	2,363	259	-136	4,392	445	-455	3,157	843	247	1,464	230	-105	1,023	-651

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

BIMI Income Statement

2023-09-30

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
REVENUES	$ 2,523,193	$ 4,932,479	$ 11,278,496	$ 10,476,224
COST OF REVENUES	2,408,038	4,229,316	6,589,020	8,928,138
GROSS PROFIT	115,155	703,163	4,689,476	1,548,086
OPERATING EXPENSES:
Sales and marketing	171,763	310,475	664,076	952,102
General and administrative	3,093,088	2,805,211	5,220,553	7,924,995
Total operating expenses	3,264,851	3,115,686	5,884,629	8,877,097
INCOME (LOSS) FROM OPERATIONS	(3,149,696)	(2,412,523)	(1,195,153)	(7,329,011)
OTHER INCOME (EXPENSE)
Interest income	53	263	379	616
Interest expense	(35,877)	(35,038)	(105,407)	(131,756)
Exchange gain (loss)	(1,338)	7,427	(3,622)	991
Amortization of convertible notes		(771,124)		(2,313,372)
Gain on disposition of former subsidiaries	107,101		304,840
Non-operating income (expense)	(54,315)	101,498	(147,618)	(2,511,520)
Other income		8,886		75,606
Total other income (expense), net	15,624	(688,088)	48,572	(4,879,435)
INCOME (LOSS) BEFORE INCOME TAXES	(3,134,072)	(3,100,611)	(1,146,581)	(12,208,446)
PROVISION FOR INCOME TAXES		(949)		6,202
NET INCOME (LOSS) FROM CONTINUING OPERATIONS	(3,134,072)	(3,099,662)	(1,146,581)	(12,214,648)
DISCONTINUED OPERATIONS
Loss from discontinued operations-held for sale	(116,718)	(758,465)	(259,820)	(957,203)
Loss from discontinued operations		(26,928)
NET INCOME (LOSS)	(3,250,790)	(3,885,055)	(1,406,401)	(13,171,851)
Less: net loss attributable to noncontrolling interest	(121,545)	(1,450)	(120,830)	(3,948)
NET INCOME (LOSS) ATTRIBUTABLE TO BIMI INTERNATIONAL MEDICIAL INC.	(3,129,245)	(3,883,605)	(1,285,571)	(13,167,903)
OTHER COMPREHENSIVE (LOSS)
Foreign currency translation adjustment	(630,330)	(399,821)	(1,156,789)	(1,367,407)
TOTAL COMPREHENSIVE INCOME (LOSS)	(3,881,120)	(4,284,876)	(2,563,190)	(14,539,258)
Less: comprehensive income (loss) attributable to noncontrolling interest	190,783	(487,621)	(1,317,844)	(1,022,664)
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO BIMI INTERNATIONAL MEDICIAL INC.	$ (4,071,903)	$ (3,797,255)	$ (1,245,346)	$ (13,516,594)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
Basic (in Shares)	6,429,980	36,395,729	4,967,278	24,037,736
INCOME (LOSS) PER SHARE
Continuing operations-Basic (in Dollars per share)	$ (0.49)	$ (0.09)	$ (0.23)	$ (0.51)
Discontinued operations-Basic (in Dollars per share)	(0.02)	(0.02)	(0.05)	(0.04)
Basic (in Dollars per share)	$ (0.51)	$ (0.11)	$ (0.28)	$ (0.55)

BIMI Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)

Sep. 30, 2023

Dec. 31, 2022

CURRENT ASSETS

Cash and cash equivalents

$ 994,131

$ 2,336,636

Accounts receivable, net

4,115,964

3,208,286

Advances to suppliers

8,737,956

6,589,759

Amount due from related parties

6,964

Inventories, net

7,086,791

7,654,242

Prepayments and other receivables

1,278,336

1,527,079

^[1]

Current assets from discontinued operations-held for sale

2,147,050

2,099,673

Total current assets

24,367,192

23,415,675

NON-CURRENT ASSETS

Deferred tax assets

184,433

190,132

Property, plant and equipment, net

1,671,628

1,703,420

Intangible assets-net

468,163

16,183

Operating lease-right of use assets

2,907,606

2,942,265

Goodwill

2,065,666

Non-current assets from discontinued operations-held for sale

3,376,261

3,761,149

Total non-current assets

10,673,757

10,678,815

^[1]

TOTAL ASSETS

35,040,949

34,094,490

^[1]

CURRENT LIABILITIES

Short-term loans

1,136,522

818,425

Long-term loans due within one year

135,809

105,965

Convertible promissory notes, net

1,108,785

Accounts payable, trade

10,438,404

10,785,531

Advances from customers

761,759

923,131

Taxes payable

26,800

71,915

Other payables and accrued liabilities

3,265,456

3,175,574

Lease liabilities

^[2]

726,309

532,630

Current liabilities from discontinued operations-held for sale

3,143,243

3,239,950

Total current liabilities

20,158,497

23,742,347

^[1]

NON-CURRENT LIABILITIES

Lease liabilities

^[2]

2,447,060

2,574,751

Long-term loans

24,374

314,786

Non-current liabilities from discontinued operations-held for sale

2,269,672

2,245,373

Total non-current liabilities

4,741,106

5,134,910

TOTAL LIABILITIES

24,899,603

28,877,257

^[1]

STOCKHOLDERS’ EQUITY

Common Stock, $0.001 par value; 200,000,000 shares authorized; 6,673,006 and 3,764,780 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively

^[3]

6,673

3,765

Additional paid-in capital

78,997,594

71,899,271

Statutory reserves

2,263,857

Accumulated deficit

(71,429,357)

(70,143,785)

Accumulated other comprehensive income (loss)

(1,132,206)

24,583

Total BIMI International Medical Inc.’s equity

8,706,561

4,047,691

NON-CONTROLLING INTERESTS

1,434,785

1,169,542

Total stockholders’ equity

10,141,346

5,217,233

Total liabilities and stockholders’ equity

35,040,949

34,094,490

^[1]

Related Party

CURRENT LIABILITIES

Amount due to related parties

$ 524,195

$ 2,980,441

^[1]

[1]	In our financial statements for the year ended December 31, 2022, we incorrectly accounted for the acquisition of Phenix Bio Inc. On July 5, 2022, we entered into a stock purchase agreement, which was subsequently amended, pursuant to which we agreed to acquire Phenix and paid a deposit of $180,000 on July 7, 2022. The closing did not occur until March 15, 2023. As of December 31, 2022, the accounting for the Phenix acquisition was incorrectly recorded as follows: (1) a long-term equity investment as a debit entry, (2) cash as a credit, and (3) other payables as a credit entry. Since the Phenix acquisition had not taken place as of December 31, 2022, it should not have been recorded as a long-term equity investment. As such, we reversed the long-term equity investment account and other payables account and recorded the deposit as a prepayment.
[2]	The Company’s operating leases include the leases of operating companies only and do not include discontinued operations-held for sale.
[3]	On February 2, 2022, we effected a reverse stock split of Common Stock at a ratio of 1-to-5 and on December 9, 2022, we effected a reverse stock split of Common Stock at a ratio of 1-to-10 (collectively, the “Reverse Splits”).

About NF Energy Saving Corp

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is headquartered in New York, New York.

CEO	Mr. Tiewei Song
WEBSITE	usbimi.com/index.html
INDUSTRY	Pharmaceuticals
EMPLOYEES	296

NF Energy Saving Corp Frequently Asked Questions

What is the ticker symbol for NF Energy Saving Corp? What does BIMI stand for in stocks?

BIMI is the stock ticker symbol of NF Energy Saving Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NF Energy Saving Corp (BIMI)?

As of Thu May 16 2024, market cap of NF Energy Saving Corp is 13.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BIMI stock?

You can check BIMI's fair value in chart for subscribers.

What is the fair value of BIMI stock?

You can check BIMI's fair value in chart for subscribers. The fair value of NF Energy Saving Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of NF Energy Saving Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BIMI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is NF Energy Saving Corp a good stock to buy?

The fair value guage provides a quick view whether BIMI is over valued or under valued. Whether NF Energy Saving Corp is cheap or expensive depends on the assumptions which impact NF Energy Saving Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIMI.

What is NF Energy Saving Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, BIMI's PE ratio (Price to Earnings) is -1.53 and Price to Sales (PS) ratio is 1.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIMI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on NF Energy Saving Corp's stock?

In the past 10 years, NF Energy Saving Corp has provided -0.323 (multiply by 100 for percentage) rate of return.